期刊文献+

适形放疗技术在非小细胞肺癌中的临床应用探究 被引量:1

Study on clinical application of conformal radiotherapy in treatment for non-small-cell lung cancer
下载PDF
导出
摘要 目的探讨三维适形放疗(3DCRT)非小细胞肺癌(NSCLC)患者的疗效和副作用。方法112例III期NSCLC患者随机分为三维适形放疗组(治疗组)和常规放疗组(常规组)各56例。治疗组予3DCRT照射,隔日1次,每次4—8Gy,总照射量40-64Gy;常规组予常规分割照射,每周治疗5次,每次1.8~2.0Gy,总照射量60。70Gy。结果3DCRT组有效率67.8%(CR+PR),完全缓解率32.1%(CR);常规组有效率28.6%,完全缓解率3.6%(P〈0.05)。3DRCT组1年生存率为71%,常规组为48%。3DCRT组放射性肺炎、放射性食管炎和血液反应率为21%、30%和71%,均略低于常规组。结论三维适形放疗可提高患者生存率,减轻放疗的毒副作用,治疗非小细胞肺癌比较有效。 Objective To investigate the results and toxic effect of three-dimensional conformal radiotherapy(3DCRT) for non-small-cell lung cancer. Methods 112 cases with stage III non-small-cell lung cancer were randomly divided into two groups; 56 in 3DRCT group and 56 in conventional group. In treatment group, patients were fractionated 3DRCT every other day and 4 - 8Gy every time. Total dosage were 40 - 70Gy.Results In 3DRCT group, the overall response rate was 67.8%(CR+PR)and complete remission rate was 32.1%(CR) while conventional group was 28.6% and 3.6%. respectively 3DRCT group was higher(P〈 0.05).Conclusion Three-dimensional conformal radiotherapy can increase the survival rate of patients and ease the toxic effect of chemotherapy. In a word, it' s an effective way to treat non- small-cell lung cancer.
作者 韦嵩 张发恩
机构地区 河池市人民医院
出处 《国际医药卫生导报》 2012年第2期211-213,共3页 International Medicine and Health Guidance News
关键词 适形放疗 非小细胞癌 Conformal radiotherapy Non-small-cell lung cancer
  • 相关文献

参考文献7

二级参考文献21

  • 1王澜,韩春,祝淑钗,迟子锋,曹彦坤.食管癌常规照射与三维适形放疗的剂量学研究[J].中华放射肿瘤学杂志,2006,15(3):176-180. 被引量:77
  • 2黄辉,郭明,王友军,杨瑞峰,魏鹏飞.三维适形在中段食管癌放疗中的应用[J].现代肿瘤医学,2006,14(8):958-960. 被引量:19
  • 3Choi N, Baumann M, Flentjie M, et al. Predictive factors in radiotherapy for non-small cell lung cancer: present status. Lung Cancer, 2001,31:43-56. 被引量:1
  • 4Martel MK, Ten-Haken RK, Hazuka MB, et al. Estimation of tumor control probability model parameters from 3-D dose distributions of nonsmall cell lung cancer patients. Lung Cancer, 1999,24:31-37. 被引量:1
  • 5Ragazzi G, Cattaneo GM, Fiorino C. Use of dose-volume histograms and biophysical models to compare 2D and 3D irradiation techniques for nonsmall cell lung cancer. Br J Radiol, 1999,72:279-288. 被引量:1
  • 6Ready NE, Vokes EE.Induction or consolidation systemic therapy in the multimodality treatment of unresectable locally advanced non-small cell lung cancer. Lung Cancer, 2003,42 Suppl 2: S65-69. 被引量:1
  • 7Dillman RO,Hemdon J,Seagren SL,et al. Improved survival in stage Ⅲ non-small-cell lung cancer: seven-year follow-up of Cancer and Group B (CALGB)8433 trial. J Natl Cancer Inst, 1996,88:1210-1215. 被引量:1
  • 8Chen LM, Ignacio L, Jacobs R, et al. Results of a phase Ⅱ concurrent chemoradiotherapy study using three-dimensional conformal radiotherapy with cisplatin and oral etoposide in stage Ⅲ non-small-cell lung cancer.Radiat Oncol Investig, 1999,7: 49-53. 被引量:1
  • 9Bradley JD.Ieumwananonthachai N,Purdy JA,et al.Gross tumer volume,critical prognosic factor in patients treated with three-dimensional conformal radiation therapy for non-small cell lung carcinoma.Int J Radiat Oncol Biol Phys,2002,52(1):49 被引量:1
  • 10Rosenzeig KE,Sim S,Mychalczak B,et al.Elective nodal irradiation in the treatment of non-small cell lung cancer with three-dimensional conformal therapy(3D-CRT).Int J Radiat Oncol Biol Phys,1999,45(1):243 被引量:1

共引文献38

同被引文献9

  • 1程晶,伍钢,吴红革.吉西他滨与三维适形放疗同步治疗局部晚期非小细胞肺癌的临床观察[J].中国肺癌杂志,2004,7(5):442-445. 被引量:13
  • 2Harari PM, Mebta MP, Ritter MA, et al. Clinical promise tempered by reality in the delivery of combined chemoradiation for common solid tumors[J].SeminRadiatOncol, 2003, 13(1): 3-12. 被引量:1
  • 3Nome S, Felulds D.Management of advanced non-small cell lung cancer, the potential role of gemcitabine[J]. Disease management health outcomes, 1999, 5(3): 167-179. 被引量:1
  • 4Arriagada R, Le Chevalier T, Quoix E, et al. ASTRO plenary: chemotherapy efkct on locally advanced non-small cell lung carcinoma: a randomized study of 353 patients[J].Int J Radiat Oncol BiolPhys, 1991, 20(6): 1183-1190. 被引量:1
  • 5Baumann M, Appold S, Petersen C, et al. Dose and fractionation concepts in the primary radiotherapy of non-small cell lung cancer[J]. Lung Cancer, 2001, 33(Suool 1): 35-45. 被引量:1
  • 6Kong FM, Ten Haken RK, Schipper MJ, et al. High-dose radiation improved local tumor control and overall survival in patients with inoperable/unresectable non-small-cell lung cancer: long-term results of a radiation dose escalation study [J].Int J Radiat Oncol Biol Phys, 2005, 63(2): 324-333. 被引量:1
  • 7Liao ZX, Komaki RR, Thames HD Jr, et al. Influence of technologic advances on outcomes in patients with unreseetahle, loeally advaneed non-small-cell lung cancer receiving concomitant ehemoradiotherapy[J].Int J Radiat Oncol Biol Phys, 2010, 76(3): 775-781. 被引量:1
  • 8Turner LM, Howard JA, Dehghanpour P, et al. Exploring the feasibility of dose escalation positron emission tomography-positive disease with intensity-modulated radiation therapy and the effects on normal tissue structures for thoracic malignancies[J].Med Dosim, 2011, 36(4): 383-388. 被引量:1
  • 9王瑞芝,王春波,郭汝涛.不能手术的Ⅲ期非小细胞肺癌的综合治疗[J].中华放射肿瘤学杂志,2001,10(2):91-93. 被引量:44

引证文献1

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部